TIDMAMS

RNS Number : 7775L

Advanced Medical Solutions Grp PLC

05 October 2016

 
   5 October 2016

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that it was notified on 30 September 2016 that Eddie Johnson, who is a Senior Manager and PDMR, had exercised 50,000 Ordinary Shares of 5p from the 2009 Executive Share Option Scheme and sold all 50,000 shares.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ----------------------------------------------------------------- 
 a)   Name: Eddie Johnson 
---  ----------------------------------------------------------------- 
 2.   Reason for the notification 
---  ----------------------------------------------------------------- 
 a)   Position/status: Senior Manager/PDMR 
---  ----------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ----------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ----------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ----------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ----------------------------------------------------------------- 
 b)        Nature of the transaction: 
             *    Exercised 50,000 Ordinary Shares of 5p from the 2009 
                  Executive Share Option Scheme; 
 
 
             *    Sale of 50,000 shares from the total shares 
                  exercised. 
---  ----------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)       Volume(s) 
       -------------  ---------- 
        GBP2.289663    50,000 
       -------------  ---------- 
---  ----------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 50,000 
       Aggregated price: GBP2.289663 
---  ----------------------------------------------------------------- 
 e)   Date of the transaction: 30/09/2016 
---  ----------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  -----------------------------------------------------------------

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                   Tel: +44 (0) 
  plc                                                1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Group Finance Director 
 
 Consilium Strategic Communications                 Tel: +44 (0) 
                                                    20 3709 5700 
 Mary-Jane Elliott / Jonathan            AMS@consilium-comms.com 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)                 Tel: +44 (0) 
                                                    20 7597 5970 
 Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 510 employees. For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBBBDGLDGBGLU

(END) Dow Jones Newswires

October 05, 2016 07:26 ET (11:26 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.